A new study by @UF startup @neuropacs! Published in Annals of Neurology, the multi-institution study revealed that spinal fluid testing and the FDA De Novo-classified software by Neuropacs capture entirely distinct dimensions of the disease process.
🔗: https://t.co/zAQRKl8h5k
Today, on #WorldParkinsonsDay, we recognize the millions of people living with Parkinsonism and the urgent need for earlier, more accurate diagnosis.
Visit https://t.co/TbyWB19y8k to learn more about our AI-driven MRI analysis platform.